
Erica L. Reagan
Articles
-
Feb 23, 2024 |
mondaq.com | Iliana L. Peters |Rebecca Frigy Romine |Erica L. Reagan
On February 8, 2024, the U.S. Department of Health and Human Services, through its Office for Civil Rights (OCR) and the Substance Abuse and Mental Health Services Administration (SAMHSA), released final rule (Final Rule) modifications to the Confidentiality of Substance Use Disorder (SUD) Patient Records regulations at 42 CFR part 2 (Part 2).
-
Feb 15, 2024 |
jdsupra.com | Iliana L. Peters |Erica L. Reagan |Rebecca Frigy Romine
On February 8, 2024, the U.S. Department of Health and Human Services, through its Office for Civil Rights (OCR) and the Substance Abuse and Mental Health Services Administration (SAMHSA), released final rule (Final Rule) modifications to the Confidentiality of Substance Use Disorder (SUD) Patient Records regulations at 42 CFR part 2 (Part 2).
-
Oct 16, 2023 |
mondaq.com | Joshua McCann |Erica L. Reagan
On October 6, 2023, the Drug Enforcement Agency (DEA) and the Department of Health and Human Services (HHS) issued a Second Temporary Rule further extending the ability to prescribe controlled substance via telemedicine through the end of 2024. On November 11, 2023, the Second Temporary Rule takes effect and extends the COVID-19 Public Health Emergency (PHE) telemedicine controlled substance prescribing flexibilities through December 31, 2024.
-
Oct 12, 2023 |
jdsupra.com | Joshua McCann |Erica L. Reagan
October 12, 2023 Joshua McCann, Pharm.D., Erica Reagan, Joelle Wilson Polsinelli + Follow x Following x Following - Unfollow Contact To embed, copy and paste the code into your website or blog: On October 6, 2023, the Drug Enforcement Agency (DEA) and the Department of Health and Human Services (HHS) issued a Second Temporary Rule, further extending the ability to prescribe controlled substances via telemedicine through the end of 2024. On November 11, 2023, the Second Temporary Rule takes...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →